In the pharmaceutical manufacturing industry, purchasing a new piece of equipment—whether it is a high shear mixer, a fluid bed dryer, or a tablet coating machine—is fundamentally different from buying standard industrial machinery. You are not just buying stainless steel and motors; you are buying compliance.
Regulatory bodies like the FDA, EMA, and WHO require documented, scientific evidence that a machine is built to specifications, installed correctly, and performs consistently. For procurement managers and project engineers, navigating the alphabet soup of equipment validation—FAT, SAT, IQ, OQ, and PQ—can be daunting.
However, understanding this lifecycle is critical. A machine without the proper validation documentation is essentially useless in a cGMP environment. In this comprehensive guide, we will break down exactly what these terms mean, why they are crucial to the procurement process, and how they protect your investment.
Phase 1: Pre-Delivery Testing (FAT)
What is FAT (Factory Acceptance Testing)?
The FAT takes place at the equipment manufacturer’s facility (the vendor) before the machine is packaged and shipped. It is a collaborative process where representatives from the pharmaceutical company travel to the vendor’s site to inspect and test the equipment.
The Goal: To verify that the equipment has been built strictly according to the approved User Requirement Specifications (URS), Functional Design Specification (FDS), and P&ID drawings.
Key Activities During FAT:
Visual Inspection: Checking dimensions, surface finishes (e.g., ensuring 316L stainless steel contact parts are polished to the correct Ra value), and welding quality.
Component Verification: Ensuring all pumps, motors, and sensors match the approved bill of materials.
Basic Functionality: Powering up the machine to test the HMI/PLC system, basic mechanical movements, and safety interlocks.
Why it matters for Procurement: Catching a design flaw or a missing component during the FAT costs very little to fix. Discovering that same error after the machine has been shipped across the globe to your cleanroom will result in massive project delays and budget overruns.
Phase 2: Post-Delivery Testing (SAT)
What is SAT (Site Acceptance Testing)?
Once the equipment successfully passes the FAT, it is shipped to the pharmaceutical company’s facility. The SAT is conducted after the machine has arrived and is placed in its final location.
The Goal: To ensure the equipment was not damaged during transit and that it interfaces correctly with the facility’s utilities (power, compressed air, chilled water, steam).
Key Activities During SAT:
Visual inspection for shipping damage.
Verifying that all components shipped match the packing list.
Confirming that facility utilities meet the machine’s requirements.
Powering on the machine in its permanent environment.
Phase 3: The Qualification Lifecycle (IQ, OQ, PQ)
While FAT and SAT are critical engineering milestones, the Qualification phases (IQ, OQ, PQ) are the formal, heavily documented steps required to satisfy cGMP regulatory audits.
1. Installation Qualification (IQ)
“Is it installed exactly as specified?” IQ is the documented proof that the equipment has been delivered and installed in accordance with the manufacturer’s guidelines and safety regulations.
What is verified: Wiring, piping connections, leveling of the machine, presence of all user manuals, and the collection of material certificates (proving the steel is actually pharmaceutical grade) and calibration certificates for all gauges.
2. Operational Qualification (OQ)
“Does it operate exactly as designed?” OQ tests the machine’s functional capabilities. This is usually done with an empty machine or using a placebo (like water or blank excipients) to test the extreme limits of the equipment.
What is tested: If a high shear mixer is designed to run at 3000 RPM, the OQ tests if it actually hits 3000 RPM smoothly. It tests power failure recovery, E-stops (Emergency Stops), alarms, password security levels (21 CFR Part 11 compliance), and heating/cooling jacket efficiencies.
3. Performance Qualification (PQ)
“Does it produce my specific product consistently?” PQ is the final hurdle. It integrates the facility, the equipment, the personnel, and your actual pharmaceutical formulation.
What is tested: The machine is run under normal, everyday manufacturing conditions using the actual active pharmaceutical ingredients (API) and batch recipes. The goal is to prove batch-to-batch consistency, content uniformity, and final product quality over multiple runs. (Note: While vendors provide IQ/OQ protocols, the PQ is typically written and executed by the pharmaceutical company).
Why Documentation is the Real Bottleneck in Procurement
For procurement professionals, negotiating the price of the hardware is only half the battle. The hidden cost of pharmaceutical equipment lies in Validation Protocols.
If a vendor delivers a machine but provides poor, incomplete, or untranslatable IQ/OQ documents, your internal QA team will spend hundreds of hours re-writing them. This delays the “Go-Live” date of the production line, costing the company millions in delayed drug-to-market revenue.
When evaluating equipment manufacturers, procurement managers must ask: “Do you provide a comprehensive, execution-ready documentation package?”
Seamless Compliance with JIANPAI Pharmaceutical Equipment
At JIANPAI, we understand that we are not just supplying machinery; we are supplying peace of mind. As a trusted manufacturer of top-tier solid dosage equipment—including Tablet Coating Machines, High Shear Mixers, and Fluid Bed Systems—we engineer compliance into every step of our process.
When you partner with JIANPAI, you receive a true Turnkey Solution:
Transparent FAT Execution: We welcome our global clients to our state-of-the-art facility for rigorous, fully documented Factory Acceptance Testing. (Video FATs are also available for remote teams).
Comprehensive Validation Packages: We supply meticulously prepared, English-language IQ and OQ protocols, alongside all necessary material certificates, welding logs, and calibration records.
21 CFR Part 11 Ready: Our advanced PLC/HMI control systems feature built-in audit trails, electronic signatures, and secure recipe management, ensuring your data integrity easily passes FDA or EMA inspections.
Don’t let validation hurdles delay your next production line. [Contact JIANPAI’s engineering and compliance team today] to discuss how our robust equipment and documentation packages can streamline your next procurement project.
Frequently Asked Questions (FAQs)
Q1: Can we skip the SAT if the FAT was 100% successful? No. The SAT is mandatory. Shipping vibrations, temperature changes, and re-assembly at your facility can alter the machine’s condition. Furthermore, the machine must be tested against your facility’s specific utilities (which were simulated during the FAT).
Q2: Who is responsible for executing the IQ and OQ? Typically, the equipment vendor (like JIANPAI) provides the blank IQ/OQ protocol documents. The execution is usually a collaborative effort: the vendor’s commissioning engineers perform the tests on-site, while the pharmaceutical company’s QA personnel witness and sign off on the results.
Q3: Does the equipment vendor handle the PQ? Usually, no. Because the Performance Qualification (PQ) involves the pharmaceutical company’s proprietary drug formulation, active ingredients, and specific Standard Operating Procedures (SOPs), the end-user’s validation team is responsible for writing and executing the PQ. However, a reliable vendor will offer technical support during this phase if machine adjustments are needed.
Skip to content 
EN 
RU 
KO 
JA 
TR 
ZH 
TH 
PT 
FR 
ES